Your session is about to expire
← Back to Search
Stress Management and Resilience Training for Stress in Air Force Personnel
N/A
Recruiting
Led By Stephen Hernandez, PhD
Research Sponsored by University of New Mexico
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up changes in self-reported pss from baseline at 12, 24, and 36 weeks post-smart completion
Awards & highlights
No Placebo-Only Group
Summary
This trial examines the effectiveness of the SMART program in helping U.S. Air Force personnel manage stress and build resilience. The program includes practices like gratitude and mindfulness and can be delivered in-person, via video calls, or through computer-based training. The study aims to find out which delivery method is most effective. The SMART program has been previously tested in various settings, including healthcare workers and employees at a medical center, showing significant improvements in stress, resilience, and mindfulness.
Who is the study for?
This trial is for active U.S. Air Force personnel at specific bases who are over 18 years old and can give informed consent. It's not open to those on temporary duty, civilians at the base, trainees in basic military training, prisoners, or anyone under 18.
What is being tested?
The trial tests Stress Management and Resilience Training (SMART) delivered either in-person/video-teleconference or via Computer-Based Training to see if it boosts resilience and reduces stress among participants over time up to 36 weeks post-training.
What are the potential side effects?
Since this intervention involves non-medical stress management techniques, traditional physical side effects are not expected; however, participants may experience varying psychological responses to the training.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ changes in self-reported cd-10 from baseline at 12, 24, and 36 weeks post-smart completion
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~changes in self-reported cd-10 from baseline at 12, 24, and 36 weeks post-smart completion
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Changes in Connor-Davidson 10-Item Scale (CD-10)
Secondary study objectives
Changes in Generalized Anxiety Disorder Scale (GAD-7)
Changes in Perceived Stress Scale (PSS)
Changes in Quality of Life (QOL)
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: RandomizationExperimental Treatment1 Intervention
At two study sites, we will randomly assign participants to the VTC/in-person group or CBT group using a ratio of 2:1 to assign participants to the VTC/in-person or CBT training modalities. We anticipate 84 participants (42 per site) will be assigned to the CBT modality and 168 (84 per site) will be assigned to the VTC/in-person modality.
Group II: Self-selectionActive Control1 Intervention
At two study sites, participants will be able to self-select which SMART training modality they will complete (VTC/in-person or CBT).We aim to recruit 250 participants in the self-selection arm.
Research Highlights
Information in this section is not a recommendation. We encourage patients to speak with their healthcare team when evaluating any treatment decision.Mechanism Of Action
Side Effect Profile
Prior Approvals
Other Research
Common treatments for improving Quality of Life (QoL) that are similar to the SMART trial include cognitive-behavioral therapy (CBT), mindfulness-based stress reduction (MBSR), and other mind-body therapies. These interventions work by teaching patients skills to manage stress, enhance emotional regulation, and improve coping mechanisms.
CBT focuses on changing negative thought patterns and behaviors, while MBSR emphasizes present-moment awareness and acceptance. These mechanisms are crucial for QoL patients as they help reduce stress, anxiety, and depression, leading to improved mental and physical well-being, better sleep, and enhanced overall life satisfaction.
Find a Location
Who is running the clinical trial?
Wright-Patterson Air Force BaseUNKNOWN
Joint Base San Antonio-LacklandUNKNOWN
Johns Hopkins UniversityOTHER
2,339 Previous Clinical Trials
14,881,131 Total Patients Enrolled
University of New MexicoLead Sponsor
388 Previous Clinical Trials
3,526,103 Total Patients Enrolled
University of Nevada, Las VegasOTHER
73 Previous Clinical Trials
13,499 Total Patients Enrolled
Nellis Air Force BaseUNKNOWN
Joint Base AndrewsUNKNOWN
TriService Nursing Research Program (Funder)UNKNOWN
Stephen Hernandez, PhDPrincipal InvestigatorUniversity of New Mexico
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I am 18 years old or older.I am under 18 years old.
Research Study Groups:
This trial has the following groups:- Group 1: Randomization
- Group 2: Self-selection
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.